Lemerond Nicole 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Lemerond Nicole
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-12-20+550→ 975 totalExercise: $4.14Exp: 2029-12-19→ Common shares (550 underlying)
Footnotes (2)
- [F1]The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner.
- [F2]On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split.